Feasibility of alcohol screening and brief intervention in primary health care in Kazakhstan: a pilot cluster randomized trial
Phase 4
- Conditions
- F10.1risky drinking
- Registration Number
- DRKS00015882
- Lead Sponsor
- niversitätsklinikum Hamburg-Eppendorf - Zentrum für Interdisziplinäre Suchtforschung der Universität Hamburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 1170
Inclusion Criteria
Ability to follow the study procedures and provision of signed informed consent
Exclusion Criteria
ever diagnosed alcohol dependency (lifetime) according to ICD 10
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibilty and acceptance of ASBI in routine primary health care in Kazakhstan measured on the basis of <br>(1) rates of eligibility, participation and retention at three months follow-up and <br>(2) quantitative and qualitative data on the patient and provider perspective
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does ASBIKaz compare to standard pharmacotherapy for F10.1 in primary care feasibility?
What genetic biomarkers predict response to brief alcohol interventions in F10.1 populations?
What adverse events are reported in phase IV cluster RCTs for alcohol screening interventions?
How do Kazakhstani cultural factors influence ASBIKaz's implementation in primary healthcare?
What combination therapies enhance brief intervention efficacy for risky drinking in F10.1?